When was OssDsign founded?

OssDsign was founded in 2011 and raised its 1st funding round 2 years after it was founded.

Where is OssDsign located?

OssDsign is headquartered in Uppsala, Sweden. It is registered at Uppsala, Uppsala county.

How many employees does OssDsign have?

As of Apr 30, 2026, the latest employee count at OssDsign is 44.

Is OssDsign a funded company?

OssDsign is a funded company, having raised a total of $19.7M across 6 funding rounds to date. The company's 1st funding round was a $***** Seed round, raised on Jul 15, 2013.

When was the latest funding round of OssDsign?

OssDsign's latest funding was a $***** Post IPO round on Jun 04, 2025, with participation from 3 investors.

Where does OssDsign rank among its competitors?

OssDsign ranks 3rd amongst 74 active competitors, of which 18 are funded. It stands 6th in terms of total funding among its competitors. The most recent competitor to raise funding was Nanochon, which secured $4.1M in Dec, 2025.

Who are the top competitors of OssDsign?

OssDsign's top competitors include BONESUPPORT, Kuros Biosciences and 4WEB Medical. Among them, Nanochon secured the most recent funding round in December, 2025.

OssDsign - 2026 Company Profile, Team, Funding, Competitors & Financials

OssDsign is a public company based in Uppsala (Sweden), founded in 2011 by Thomas Engstrand, Hakan Engqvist, Bo Qwarnstrom and Jonas Aberg. It operates as a Developer of regenerative 3D-printed orthopedic implants for craniofacial bone defects and trauma. OssDsign has raised $19.7M in funding from investors like SEB, Eiffel Investment Group and Fouriertransform. The company has 74 active competitors, including 18 funded and 11 that have exited. Its top competitors include companies like BONESUPPORT, Kuros Biosciences and 4WEB Medical.

Company Details

Developer of regenerative 3D-printed orthopedic implants for craniofacial bone defects and trauma. Its implants incorporate a proprietary calcium phosphate-based material composition, reinforced by titanium, and CAD-based manufacturing and design. It uses 3D printing technologies to produce implants using materials like titanium combined with cured ceramic tiles. Its products have applications in the reconstruction of facial bone after trauma, tumor resection or growth retardation due to irradiation, and the repair of hereditary facial defects such as paranasal augmentation in cleft patients and correction of hemifacial microsomia.

Website: www.ossdsign.com/
Social
Registered Address: Uppsala, Uppsala county

Key Metrics

Founded Year

2011

Location

Uppsala, Sweden

Stage

Public

Total Funding

$19.7M in 6 rounds

Latest Funding Round

Post IPO, Jun 04, 2025, $*****

Investors

SEB & 11 more

Ranked

3^rd among 74 active competitors

Employee Count

44 as on Apr 30, 2026

Investment & Acquisitions

SIRAKOSS

Similar Companies

BONESUPPORT & 89 more

Exit Details

Public

View OssDsign's full profile

OssDsign is associated with 2 legal entities given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count	Documents
Ossdsign Ab CIN: 0799.226.055 , Belgium, Active	Mar 06, 2023	-	-	-
Ossdsign Ab CIN: 556841-7546 , Sweden, Active	Dec 31, 2010	-	-	-

OssDsign got listed on May 24, 2019.

Click here to take a look at OssDsign's IPO in detail

OssDsign has raised a total funding of $19.7M over 6 rounds. Its first funding round was on Jul 15, 2013. Its latest funding round was a Post IPO round on Jun 04, 2025 for $*****. 3 investors participated in its latest round. OssDsign has 12 institutional investors.

Here is the list of recent funding rounds of OssDsign:

Filter this list

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Jun 04, 2025	6705503	Post IPO	8275690	5159700	5492557	9447489
Sep 27, 2023	3819959	Post IPO	2442364	5524807	7610566	Linc & 1 more
Feb 12, 2019	8719987	Series A	2051604	1936777	Eiffel Investment Group	1673104

Access funding benchmarks and valuations. Sign up today!

View details of OssDsign's funding rounds and investors

The founders of OssDsign are Thomas Engstrand, Hakan Engqvist, Bo Qwarnstrom and Jonas Aberg.

Here are the details of OssDsign's key team members:

Thomas Engstrand: Co-Founder of OssDsign.
Hakan Engqvist: Co-Founder of OssDsign.
Bo Qwarnstrom: Co-Founder of OssDsign.
Jonas Aberg: Co-Founder of OssDsign.

View details of OssDsign's Founder profiles and Board Members

OssDsign's employee count trend

OssDsign has 44 employees as of Apr 26. Here is OssDsign's employee count trend over the years:

Uncover OssDsign's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of OssDsign include BONESUPPORT, Kuros Biosciences and 4WEB Medical. Here is the list of Top 10 competitors of OssDsign, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	BONESUPPORT 2000, Lund (Sweden), Public	Injectable, synthetic bone substitutes for remodeling	$101M	Tellacq Partners, Stage Capital & 15 others	60/100
2nd	Kuros Biosciences 2000, Schlieren (Switzerland), Public	Provider of smart solutions for bone disease management	$24.6M	Renaissance, LifeCare Partners & 12 others	60/100
3rd	OssDsign 2011, Uppsala (Sweden), Public	Developer of regenerative 3D-printed orthopedic implants for craniofacial bone defects and trauma	$19.7M	Linc, Eiffel Investment Group & 10 others	59/100
4th	4WEB Medical 2008, Frisco (United States), Series A	Innovative orthopedic implant company focused on advanced structural design and fusion	$12.5M	SWK Holdings, National Science Foundation	58/100
5th	Nanochon 2016, Burke (United States), Seed	Developer of 3D-printed implants for treating joint injuries	$11.3M	cultivate(MD), University of Virginia & 11 others	55/100
6th	ISTO Biologics 1997, St. Louis (United States), Acquired	Developer of treatments for cartilage and bone problems	$40.7M	Life Sciences Partners, USPTO & 7 others	54/100
7th	Askel Healthcare 2017, Helsinki (Finland), Funding Raised	Developer of regenerative medicines for cartilage & bone tissue regeneration	-	Dualcore, EIC Fund & 2 others	52/100
8th	OSSTEC 2021, London (United Kingdom), Series A	Developer of regenerative orthopedic implants	$4.68M	SFC Capital, Empirical Ventures & 9 others	47/100
9th	K2M 2004, Leesburg (United States), Acquired	Spine solutions: implants, instruments, biologics, and enabling technologies	$21.5M	Bay City Capital, New Science Ventures & 3 others	47/100
10th	Ossiform 2017, Odense (Denmark), Series B	Developer of 3D printed resorbable bone implants	$20.6M	West Hill Capital, Asimov Ventures & 21 others	42/100